Sat.May 07, 2022

article thumbnail

Avantor Announces Investment in Manufacturing and Distribution Hub in Singapore to Serve Rapidly Growing Asia Pacific Biopharma Industry

Pharma Mirror

Singapore, Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, today announced it will create a new manufacturing and distribution Hub in Singapore, by integrating its existing distribution facility with new manufacturing operations.

article thumbnail

HKUST-led research reveals a novel molecular mechanism that regulates secretion of sonic hedgehog, shedding light on cancer treatments

Scienmag

A research led by Hong Kong University of Science and Technology (HKUST) has revealed a novel mechanism that regulates secretion of sonic hedgehog (Shh), a key signaling molecular that plays an important role in cancer progression, in mammals, opening the door to novel therapeutic strategies for cancer induced by the hedgehog signaling pathway. Credit: HKUST […].

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

ImaginAb Announces New Supply Agreement to Supply Genmab A/S with its Investigational CD8 ImmunoPET Agent

Pharma Mirror

Los Angeles, CA, USA, ImaginAb, Inc., a market leading global biotechnology company focused on developing next generation ImmunoPET imaging agents and therapeutic radiopharmaceuticals (RPT), is pleased to announce it has signed a new multi-year, non-exclusive supply agreement with Genmab A/S, an international biotechnology company. Under the terms of the agreement, ImaginAb will provide a non-exclusive, worldwide license to Genmab A/S to use its investigational CD8 ImmunoPET imaging technology (

article thumbnail

Helping Clinics Help Patients With Adopt-a-Lab 

Intouch Solutions

Recently, we told you about our new philanthropy program: The Give Back. We’d love to share more about one of our signature Give Back partnerships with Adopt-a-Lab! Adopt-a-Lab is a project that’s improving free health clinics nationwide through Heart to Heart International (HHI), a nonprofit Intouch has been working with for years. These clinics serve communities in which residents often face many extra barriers to getting the healthcare they need.

52
article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

article thumbnail

Avantor Announces Investment in Manufacturing and Distribution Hub in Singapore to Serve Rapidly Growing Asia Pacific Biopharma Industry

Pharma Mirror

Singapore, Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, today announced it will create a new manufacturing and distribution Hub in Singapore, by integrating its existing distribution facility with new manufacturing operations.

article thumbnail

Helping Clinics Help Patients With Adopt-a-Lab 

Intouch Solutions

Recently, we told you about our new philanthropy program: The Give Back. We’d love to share more about one of our signature Give Back partnerships with Adopt-a-Lab! . Adopt-a-Lab is a project that’s improving free health clinics nationwide through Heart to Heart International (HHI), a nonprofit Intouch has been working with for years. . These clinics serve communities in which residents often face many extra barriers to getting the healthcare they need.

52

More Trending

article thumbnail

In-person socialization down, but social media isn’t to blame, researcher says

Scienmag

LAWRENCE – Jeffrey Hall is passionate about two things in particular – friendship —- link to: [link] ——- and social media – and he thinks the latter is too often mistaken as the enemy of the former. His latest article reviews the best available evidence to debunk the “social displacement hypothesis” that holds that use […].

article thumbnail

Which pharmaceutical companies have the most SPCs in France?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in France. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…. The post Which pharmaceutical companies have the most SPCs in France? appeared first on DrugPatentWatch - Make Better Decisions.

52
article thumbnail

Entry Level Clinical Research in Israel

ECRG Media's Clinical Research Podcast

Entry Level Clinical Research in Israel Send in a voice message: [link] Entry Level Clinical Research in Israel Send in a voice message: [link]

article thumbnail

Entry Level Clinical Research in Israel

ECRG Media's Clinical Research Podcast

Entry Level Clinical Research in Israel. Send in a voice message: [link] Entry Level Clinical Research in Israel.

article thumbnail

The New Age of Decentralized Clinical Trials

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations